IL97638A - Bi-functional compounds and compositions, pharmaceutical preparations containing them and a method for treating them with neuroimmunological diseases in non-human mammals - Google Patents

Bi-functional compounds and compositions, pharmaceutical preparations containing them and a method for treating them with neuroimmunological diseases in non-human mammals

Info

Publication number
IL97638A
IL97638A IL9763891A IL9763891A IL97638A IL 97638 A IL97638 A IL 97638A IL 9763891 A IL9763891 A IL 9763891A IL 9763891 A IL9763891 A IL 9763891A IL 97638 A IL97638 A IL 97638A
Authority
IL
Israel
Prior art keywords
oxo
dihydro
purin
ait
solution
Prior art date
Application number
IL9763891A
Other languages
English (en)
Hebrew (he)
Other versions
IL97638A0 (en
Original Assignee
Glasky Alvin J
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glasky Alvin J filed Critical Glasky Alvin J
Publication of IL97638A0 publication Critical patent/IL97638A0/xx
Publication of IL97638A publication Critical patent/IL97638A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
IL9763891A 1990-03-28 1991-03-21 Bi-functional compounds and compositions, pharmaceutical preparations containing them and a method for treating them with neuroimmunological diseases in non-human mammals IL97638A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/500,789 US5091432A (en) 1990-03-28 1990-03-28 9-substituted hypoxanthine bi-functional compounds and their neuroimmunological methods of use

Publications (2)

Publication Number Publication Date
IL97638A0 IL97638A0 (en) 1992-06-21
IL97638A true IL97638A (en) 1999-03-12

Family

ID=23990941

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9763891A IL97638A (en) 1990-03-28 1991-03-21 Bi-functional compounds and compositions, pharmaceutical preparations containing them and a method for treating them with neuroimmunological diseases in non-human mammals

Country Status (17)

Country Link
US (1) US5091432A (ja)
EP (1) EP0522082B1 (ja)
JP (1) JP3198335B2 (ja)
KR (1) KR100194162B1 (ja)
AT (1) ATE154880T1 (ja)
AU (1) AU7678191A (ja)
CA (1) CA2079342C (ja)
CS (1) CS85991A3 (ja)
DE (1) DE69126701T2 (ja)
DK (1) DK0522082T3 (ja)
ES (1) ES2104700T3 (ja)
GR (1) GR3024904T3 (ja)
IE (1) IE81123B1 (ja)
IL (1) IL97638A (ja)
NZ (1) NZ237574A (ja)
TW (1) TW279865B (ja)
WO (1) WO1991014434A1 (ja)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5801184A (en) * 1994-07-25 1998-09-01 Glasky; Alvin J. Carbon monoxide dependent guanylyl cyclase modifiers and methods of use
US6338963B1 (en) * 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
WO1996003125A1 (en) * 1994-07-25 1996-02-08 Glasky Alvin J Carbon monoxide dependent guanylyl cyclase modifiers
US5447939A (en) * 1994-07-25 1995-09-05 Glasky; Alvin J. Carbon monoxide dependent guanylyl cyclase modifiers and methods of use
US20020022657A1 (en) * 1998-02-11 2002-02-21 Francine Gervais Methods for modulating neuronal cell death
WO1999057120A1 (en) * 1998-05-04 1999-11-11 Neotherapeutics, Inc. Novel serotonin-like 9-substituted hypoxanthine and methods of use
AU3879899A (en) * 1998-05-04 1999-11-23 Neotherapeutics, Inc. Novel dopamine-like 9-substituted hypoxanthine and methods of use
US6297226B1 (en) 1999-10-15 2001-10-02 Neotherapeutics, Inc. Synthesis and methods of use of 9-substituted guanine derivatives
US6288069B1 (en) 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
EP1537110B1 (en) * 1999-12-06 2007-01-17 Euro-Celtique, S.A. Triazospiro compounds having nociceptin receptor affinity
US6407237B1 (en) * 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
WO2002004448A2 (en) * 2000-07-07 2002-01-17 Neotherapeutics, Inc. Methods for treatment of drug-induced peripheral neuropathy and related conditions
US20020128264A1 (en) * 2000-07-07 2002-09-12 Taylor Eve M. Methods for treatment of conditions affected by activity of multidrug transporters
US20020040031A1 (en) * 2000-07-07 2002-04-04 Glasky Michelle S. Methods for prevention of accumulation of amyloid beta peptide in the central nervous system
US20020040032A1 (en) * 2000-07-07 2002-04-04 Glasky Michelle S. Methods for stimulation of synthesis of synaptophysin in the central nervous system
WO2002058736A2 (en) * 2000-12-12 2002-08-01 Neotherapetics, Inc. Use of 9-substituted purine analogues and other molecules to stimulate neurogenesis
US20020156277A1 (en) * 2001-04-20 2002-10-24 Fick David B. Synthesis and methods of use of purine analogues and derivatives
US6759427B2 (en) * 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
US6906190B2 (en) * 2002-01-04 2005-06-14 Ribapharm Inc. Inhibitors for de novo-RNA polymerases and methods of identifying targets for same
CA2544573A1 (en) 2003-11-03 2005-06-02 Probiodrug Ag Combinations useful for the treatment of neuronal disorders
US7473728B2 (en) * 2004-12-16 2009-01-06 The Goodyear Tire & Rubber Company Dual phase rubber composition and tire with nanocomposite-containing sidewall thereof
WO2006085149A2 (en) 2004-12-22 2006-08-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
EP1968561B8 (en) * 2005-12-22 2010-10-20 Kiacta Sàrl Treatment of diabetic nephropathy
DK2089417T3 (en) * 2006-10-12 2015-03-23 Bhi Ltd Partnership Methods, Compounds, Compositions and Vehicles for Delivery of 3-Amion-1-Propanesulfonic Acid
CN101730529A (zh) * 2006-12-22 2010-06-09 贝鲁斯健康(国际)有限公司 用于治疗代谢疾病和糖尿病的方法、化合物和组合物
JP6234471B2 (ja) * 2012-11-21 2017-11-22 ゾエティス・サービシーズ・エルエルシー スピロ環状イソキサゾリン誘導体の合成
CN115521306B (zh) * 2022-09-26 2024-03-26 贵州大学 一种1,2,3,4-四氢-β-咔啉衍生物及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3321369A (en) * 1965-05-26 1967-05-23 Abbott Lab Method of enhancing learning rate and retention level in warm blooded animals
US3484521A (en) * 1966-06-23 1969-12-16 Int Chem & Nuclear Corp Enhancement of memory processes in mammals with basic addition salts of ribonucleic acid
US4221910A (en) * 1978-09-15 1980-09-09 Newport Pharmaceuticals International, Inc. 9-(Hydroxy alkyl)purines
US4221909A (en) * 1978-09-15 1980-09-09 Sloan-Kettering Institute For Cancer Research P-Acetamidobenzoic acid salts of 9-(hydroxyalkyl) purines
US4221794A (en) * 1979-06-21 1980-09-09 Newport Pharmaceuticals International, Inc. Method of imparting immunomodulating and antiviral activity
IL64501A (en) * 1980-12-22 1985-07-31 Astra Laekemedel Ab 9-substituted 4-hydroxybutyl guanine derivatives,their preparation and antiviral use
US4728605A (en) * 1984-07-31 1988-03-01 Fudenberg Herman H Methods for recognizing and diagnosing subsets of Alzheimer's disease associated with immune system dysfunction, and for the in vitro testing of possible therapeutic agents for treatment of same
US4952693A (en) * 1984-10-12 1990-08-28 Warner-Lambert Company Oxazolo-pyrimidine derivatives

Also Published As

Publication number Publication date
JPH05508390A (ja) 1993-11-25
ES2104700T3 (es) 1997-10-16
AU7678191A (en) 1991-10-21
EP0522082A4 (en) 1993-06-09
EP0522082B1 (en) 1997-07-02
TW279865B (ja) 1996-07-01
JP3198335B2 (ja) 2001-08-13
IL97638A0 (en) 1992-06-21
KR100194162B1 (ko) 1999-06-15
WO1991014434A1 (en) 1991-10-03
DE69126701T2 (de) 1997-12-04
EP0522082A1 (en) 1993-01-13
IE910994A1 (en) 1991-10-09
DK0522082T3 (da) 1997-07-21
NZ237574A (en) 1993-09-27
DE69126701D1 (de) 1997-08-07
ATE154880T1 (de) 1997-07-15
US5091432A (en) 1992-02-25
CA2079342C (en) 2001-10-23
CA2079342A1 (en) 1991-09-29
GR3024904T3 (en) 1998-01-30
IE81123B1 (en) 2000-03-22
CS85991A3 (en) 1992-02-19

Similar Documents

Publication Publication Date Title
US5091432A (en) 9-substituted hypoxanthine bi-functional compounds and their neuroimmunological methods of use
TWI805664B (zh) Ｔｌｒ７/８拮抗劑及其用途
KR101879422B1 (ko) Btk 및/또는 jak3 키나제의 활성을 억제하는 화합물
EP2010505B1 (en) Heterocyclic compounds and uses thereof in the treatment of sexual disorders
TWI711610B (zh) 布魯頓氏酪胺酸激酶抑制劑
US11555042B2 (en) Macrocyclic compounds as TRK kinases inhibitors
EP3765462B1 (en) Substituted (2-azabicyclo [3.1.0] hexan-2-yl) pyrazolo [1, 5-a] pyrimidine and imidazo [1, 2-b] pyridazine compounds as trk kinases inhibitors
US20150299171A1 (en) Inhibitors of bruton's tyrosine kinase
KR20080081177A (ko) 야누스 키나아제 억제제인 술폰아미도아닐린 유도체
CN101242839A (zh) 氮杂吲唑化合物及其使用方法
CN115066438A (zh) 用于降解胞外蛋白的asgpr结合化合物
JP2000515550A (ja) サイクリン依存キナーゼ２およびＩκＢ―αのプリン阻害剤
KR20020041456A (ko) 9-치환 구아닌 유도체의 합성 및 사용 방법
US20240199623A1 (en) SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINES AS CFTR MODULATORS
CN102227429B (zh) 作为趋化因子受体调节剂的3-氨基环戊烷羧酰胺
KR20190025545A (ko) 특정 단백질 키나제 억제제
RU2749038C2 (ru) Замещенные пирроло[2,3-d]пиридазин-4-оны и пиразоло[3,4-d]пиридазин-4-оны в качестве ингибиторов протеинкиназы
RU2201930C2 (ru) Применение производных теофиллина для лечения и профилактики состояний шока, новые соединения ксантина
US6583138B1 (en) Heterocyclic-ring condensed benzothiazine compound
MXPA02004935A (es) Uso de derivados de hipoxantina 9-sustituida para estimular la regeneracion de tejido nervioso.
SK24393A3 (en) Carboxylic acid esters with 2-amino-7-(1,3-dihydroxy- -2-propoxymethyl)purine, their preparation and use

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees